Abstract: As the fight against the deadly Covid 19 pandemic continues worldwide, several complications were being reported in patients who have recovered from Covid. One such deadly complication that has been reported recently in patients in India who were tested positive for Covid-19 and are gradually recovering was a fungal disease called mucormycosis, or black fungus. As hundreds of cases had been reported across the country, this had caused an additional wave of panic among the population. Post-Covid-19 patients who are more susceptible to mucormycosis are those with a history of poorly controlled diabetes mellitus and also those who are immunocompromised and have been treated with steroids and other medications for Covid-19. This brief review briefly discusses the epidemiology of mucormycosis, its potential pathophysiology in the post-Covid scenario, its clinical presentation, and its diagnosis and treatment. This brief review briefly discusses the epidemiology of mucormycosis